TOCYMA Trademark

Trademark Overview

On Wednesday, January 29, 2020, a trademark application was filed for TOCYMA with the United States Patent and Trademark Office. The USPTO has given the TOCYMA trademark a serial number of 88776812. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Friday, June 11, 2021. This trademark is owned by Fresenius Kabi Deutschland GmbH. The TOCYMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment of immunological diseases and disorders, inflammatory diseases and disorders including giant cell arteritis (GCA), oncological diseases and disorders and viral infections, as well as treatment of CAR T-cell induced cytokine release syndrome
tocyma

General Information

Serial Number88776812
Word MarkTOCYMA
Filing DateWednesday, January 29, 2020
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateFriday, June 11, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 24, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment of immunological diseases and disorders, inflammatory diseases and disorders including giant cell arteritis (GCA), oncological diseases and disorders and viral infections, as well as treatment of CAR T-cell induced cytokine release syndrome

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateFriday, June 11, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFresenius Kabi Deutschland GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBad Homburg 61352
DE
Party NameFresenius Kabi Deutschland GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBad Homburg 61352
DE

Trademark Events

Event DateEvent Description
Friday, June 11, 2021ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Friday, June 11, 2021ABANDONMENT - AFTER INTER PARTES DECISION
Friday, June 11, 2021OPPOSITION TERMINATED NO. 999999
Friday, June 11, 2021OPPOSITION DISMISSED NO. 999999
Monday, May 24, 2021OPPOSITION INSTITUTED NO. 999999
Wednesday, November 25, 2020EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, November 24, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 24, 2020PUBLISHED FOR OPPOSITION
Wednesday, November 4, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 19, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 19, 2020EXAMINER'S AMENDMENT ENTERED
Monday, October 19, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 19, 2020EXAMINERS AMENDMENT E-MAILED
Monday, October 19, 2020EXAMINERS AMENDMENT -WRITTEN
Friday, September 18, 2020PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, September 18, 2020WITHDRAWN FROM PUB - EXAMINING ATTORNEY REQUEST
Friday, September 18, 2020ATTORNEY REVIEW COMPLETED
Friday, September 18, 2020LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Friday, September 18, 2020LETTER OF PROTEST EVIDENCE FORWARDED
Tuesday, July 21, 2020ASSIGNED TO LIE
Sunday, July 19, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, July 19, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, July 19, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 13, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 20, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 20, 2020NON-FINAL ACTION E-MAILED
Monday, April 20, 2020NON-FINAL ACTION WRITTEN
Saturday, April 18, 2020ASSIGNED TO EXAMINER
Tuesday, February 4, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, February 1, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

tocyma disorders diseases cell treatment infections viral well syndrome cytokine oncological